F Robiller
Impact in
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Lung Cancer Research Studies
-
- Neuroblastoma Research and Treatments
Papers in
-
- Radiopharmaceutical Chemistry and Applications 3
- Surgery 2
- Co-authors
- Richard P. Baum (3 shared papers)Dirk Müeller (2 shared papers)Harshad Kulkarni (3 shared papers)Aviral Singh (2 shared papers)Ulrich Reineke (1 shared paper)Dirk Zboralski (1 shared paper)Aileen Hoehne (1 shared paper)Jingjing Zhang (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)Journal of Nuclear Medicine (1 paper)European Radiology (1 paper)Oncotarget (1 paper)Medizinische Klinik (1 paper)
- Partner nations
- GermanyUnited StatesThailand
In The Last Decade
F Robiller
10 papers receiving 358 citations
F Robiller's Hit Papers
Peers
Comparison fields: 5 of 44
- Oncology 283
- Neurology 79
- Radiology, Nuclear Medicine and Imaging 117
- Epidemiology 134
- Cancer Research 58
Countries citing papers authored by F Robiller
This map shows the geographic impact of F Robiller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Robiller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Robiller more than expected).
Fields of papers citing papers by F Robiller
This network shows the impact of papers produced by F Robiller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Robiller. The network helps show where F Robiller may publish in the future.
Co-authors
The 25 scholars most cited alongside F Robiller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results Hit paper breakdown → | 2021 | 210 |
| 2 | 2018 | 112 | |
| 3 | 2000 | 31 | |
| 4 | 2005 | 3 | |
| 5 | The budgerigar (Melopsittacus undulatus) as endocrinological test model. Thyroxine transport in blood. | 1975 | 3 |
| 6 | 2022 | 1 | |
| 7 | 2002 | 1 | |
| 8 | [Comparison of function and morphology of the thyroid gland of the budgerigar (Melopsittacus undulatus)]. | 1972 | 1 |
| 9 | [The fate with time of protein-bound 131-iodine in the budgerigar (Melopsittacus undulatus) with simultaneous measurement of activity in the liver and other organs]. | 1974 | 1 |
| 10 | Autoradiographic studies on iodine distribution in the thyroid gland of the budgerigar (Melopsittacus undulatus). | 1972 | 1 |
About F Robiller
F Robiller is a scholar working on Radiology, Nuclear Medicine and Imaging, Surgery, Ecology, Oncology and Epidemiology, having authored 10 papers that have together received 364 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (3 papers), Physiological and biochemical adaptations (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Comparative Animal Anatomy Studies (1 paper), Neurobiology and Insect Physiology Research (1 paper), Nanoplatforms for cancer theranostics (1 paper), Prostate Cancer Treatment and Research (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Oncology (283 citations), Neurology (79 citations), Radiology, Nuclear Medicine and Imaging (117 citations), Epidemiology (134 citations) and Cancer Research (58 citations). F Robiller has collaborated with scholars based in Germany, United States and Thailand. Frequent co-authors include Richard P. Baum, Dirk Müeller, Harshad Kulkarni, Aviral Singh, Ulrich Reineke, Dirk Zboralski, Aileen Hoehne, Jingjing Zhang, Christiane Smerling and Christiane Schuchardt. Their work appears in journals such as Journal of Clinical Oncology, Journal of Nuclear Medicine, European Radiology, Oncotarget and Medizinische Klinik.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.